FANCM and breast cancer: Altogether, the combined prevalence of the studied high and moderate-risk variants in the unselected breast cancer cohort was 7.1% (165/2336), and 8.9% (208/2334) when including the FANCM variants (c.5101C > T and c.5791C > T with OR < 1) (Table 1).